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1. Introduction
The ability to detect individual molecules—at first sight—
holds the promise to reach the ultimate sensitivity. Thus, it is
not surprising to see a surge in the number and variety of
single-molecule approaches. While there have been many
review articles on the advantages of single-molecule fluores-
cence spectroscopy in the field of biophysics,[1] more recent
reviews have discussed the potential and limitations of single-
molecule applications for analytical chemistry.[2] Our Review
is focused on single-molecule bioaffinity assays and does not
cover similar techniques for fundamental biophysical or
biomolecular research. Furthermore, it was necessary to
limit the Review to optical single-molecule techniques. Other
emerging single-molecule applications of electrochemical[3]
and force-based techniques[4] can be found elsewhere. As the
labeling technique is the key element for the ability to detect
a single analyte target molecule, the structure of the Review
follows different types of optical detection labels. We have
also included illustrative examples of label-free optical
techniques reported for single-molecule assays.[5]
Most bioaffinity techniques rely on antibodies, though
aptamers or molecularly imprinted polymers (MIPs)[6] have
also been used to specifically bind and capture an analyte of
interest. Antibodies can be generated with high specificity
against almost any analyte. Only the affinity ceiling limits
their binding constant to approximately 1010m@1,[7] which is
much lower than that of (strept)avidin–biotin binding
(1014m@1).[8] Since antibodies are rather large, cameloid anti-
bodies that consist only of a single binding site have attracted
some attention. The advantage of aptamers is the easy large-
scale production, whereas MIPs stand out for their high
chemical stability. MIPs are especially useful for the detection
of small molecules with a rigid structure. MIPs, however, seem
less suitable for the detection of structurally flexible analytes
such as proteins.
For detecting the binding event, two approaches can be
distinguished: 1) In label-free assays, the binding of the
analyte to the detection element results in a signal change that
can be directly measured. 2) In the so-called sandwich format,
a second affinity reagent, which carries a signal-generating
label, binds to the analyte. As a detection label can strongly
amplify the signal, this approach is more amenable for
implementing single-molecule assays. The first immunoassays
used radioactive labels,[9] but enzyme labels have gradually
replaced radionuclides for safety reasons and because each
enzyme label generates thousands of measurable product
molecules (intrinsic signal-amplification step). The enzyme-
linked immunosorbent assay (ELISA) is still considered to be
the gold standard for the quantitative measurement of various
analytes ranging from clinical diagnosis to environmental
applications not the least because it is relatively easy to
perform.
The ability to detect low concentrations of analytes and in particular
low-abundance biomarkers is of fundamental importance, e.g., for
early-stage disease diagnosis. The prospect of reaching the ultimate
limit of detection has driven the development of single-molecule bio-
affinity assays. While many review articles have highlighted the
potentials of single-molecule technologies for analytical and diagnostic
applications, these technologies are not as widespread in real-world
applications as one should expect. This Review provides a theoretical
background on single-molecule—or better digital—assays to critically
assess their potential compared to traditional analog assays. Selected
examples from the literature include bioaffinity assays for the detection
of biomolecules such as proteins, nucleic acids, and viruses. The
structure of the Review highlights the versatility of optical single-
molecule labeling techniques, including enzymatic amplification,
molecular labels, and innovative nanomaterials.
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Over the last 60 years, the development of immunoassays
has been mainly driven by making measurements more
sensitive, specific, and reproducible. While conventional
ELISAs can measure picomolar concentrations of analytes,
higher sensitivities are required because even few molecules
of toxins can be harmful,[10] individual pathogens can initiate
an infectious disease,[11] and trace amounts of a cancer marker
indicate the beginning of a malignant transformation.[12]
Additionally, the development of more sensitive immuno-
assays is essential for the discovery of new potential
biomarkers that are not accessible using current diagnostic
tests.[13]
A conventional ELISA is performed in a laboratory and
requires several washing steps and relatively long incubation
times. Thus, the second line of immunoassay development has
aimed at a faster throughput using lower sample volumes, and
assays that can be performed directly at the site of sample
collection (on-site testing), for example, at the bedside for
diagnostic tests,[14] or in the field for environmental and food
products applications. In diagnostics, such assays are com-
monly known as point-of-care (POC) tests.[15] Minimally
invasive sample collection methods, for example, from urine
or saliva, and no washing steps are preferred to maintain the
user-friendly operation of POC tests. The most famous
antibody-based POC test is the home pregnancy test, a very
successful example of a lateral flow assay (LFA) first
described in the 1980s.[16] The wide acceptance and user-
friendliness is a precondition for POC methods to become
a cornerstone in the predictive, preventive, personalized, and
participatory medicine, commonly termed P4 medicine.[17]
The family of bioaffinity assays, in particular immuno-
assays, can be subdivided depending on the detection label as
shown in Figure 1. 1) Enzyme labels represent the central
branch and continue to be the most common detection route.
2) Fluorescent molecular labels are in principle easier to
implement because the detection antibody is directly labeled
with a fluorophore and no enzymatic amplification step is
necessary. The simplest form, the fluorescence immunoassay
(FIA), however, is limited by background fluorescence with-
out the advantage of enzymatic amplification. In addition to
the direct intensity-based fluorescence detection, this scheme
was adapted for signal amplification (e.g. by Immuno PCR) or
for the development of homogeneous assays using fluores-
cence polarization. Nevertheless, the non-zero background of
fluorescence remains. A decisive breakthrough was the
development of time-resolved (TR) detection by employing
lanthanide-based labels that display a long lifetime (micro-
seconds) compared to organic fluorophores (nanoseconds).[18]
In a time-gated approach, after luminescence excitation, the
signal acquisition is delayed by a few microseconds to let the
autofluorescence signal decay, and only the specific signal of
the lanthanide is recorded. The TR-FIA is a background-free
optical detection method that, however, requires a more
sophisticated instrumental setup. The dissociation-enhanced
lanthanide fluorescent immunoassay (DELFIA) is the most
prominent TR-FIA system on the market.[19]
Nanoparticles (NP) currently constitute the most rapidly
branching labeling strategy for immunoassays.[20] Colloidal
gold has been used for the readout of LFAs. Due to their
plasmonic properties, gold nanoparticles (Au NPs) strongly
absorb and scatter light such that a direct color read-out by
eye is possible, and the user is able to make a yes/no decision.
In the meantime, the use of NPs in immuno- and other
bioaffinity assays has experienced a fast growth as a result of
concurrent progress in nanomaterials research. Plasmonic
NPs are now in widespread use, but also other NPs and
nanocomposites have been designed that enable a convenient
optical readout. For example, quantum dots (QDs) are
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a better alternative to organic fluorophores because they are
more photostable and brighter, which is an important feature
for single-molecule applications. Photon-upconversion nano-
particles (UCNPs) are another emerging class of labels that
can be excited by near-infrared light and emit shorter-
wavelength light. The anti-Stokes emission prevents auto-
fluorescence and light scattering and thus allows for an optical
readout without background interference.[21] The back-
ground-free detection renders UCNPs an excellent candidate
for single-molecule applications.[22] Furthermore, nanocon-
tainers such as liposomes can be filled with large numbers of
fluorophores to generate a strong signal. In contrast to
enzyme labels that generate the fluorophores in situ, the
encapsulated fluorophores are released on demand from the
nanocontainer to avoid self-quenching inside the confined
environment.[23] There are also mixed detection schemes, e.g.,
in the form of electrochemiluminescence that generates
a strong signal without background.
All three branches shown in Figure 1 have now blossomed
into single-molecule assays as a consequence of innovative
assay designs as well as advances in instrumental techniques,
detector sensitivities and data processing capabilities. In
simple terms, single-molecule assays can be considered as
the result of driving conventional assays to the highest
sensitivity—either by increasing the specific signal to very
high levels or by background reduction. Therefore, any
standard analytical method can, in principle, reach “single-
molecule sensitivity” but background interference such as
matrix effects, readout noise or non-specific binding typically
prevents it.
It is furthermore essential to understand that the ability to
detect a single molecule is not synonymous with the most
sensitive analytical assay. For example, some immunoassays
from the pre-single-molecule era actually had higher sensi-
tivities than current single-molecule assays.[24] If we shift our
attention from the detection of a single molecule as the
“ultimate” sensitivity to the distinct readout mode, however,
it becomes clear that single-molecule detection is a unique
and powerful tool for background reduction. Since the signal
of a single detection label can be reliably distinguished from
the background noise of the instrument and reagents, the
measurement is completely independent of background
fluctuations. Thus, the term “digital assay” (as opposed to
a conventional “analog assay”) is a much better description of
the advantages conferred by single-molecule detection in
analytical chemistry. The digital readout, in turn, makes the
measurement more robust and thus indirectly leads to lower
detection limits.
The signal-to-noise (S/N) ratio determines whether
a single molecule can be detected or not. The strength of
the specific optical signal depends on the type of label and can
be strongly amplified, as discussed in the next section. In
a digital assay, however, each detectable response is derived
from a single analyte molecule, and thus the specific signal
strength is ultimately fixed. The only option to assure single-
molecule detection is the reduction of the background signal,
which decreases with the detection volume. This problem has
been extensively discussed for fluorescence spectroscopy, one
of the earliest and most important methods for single-
molecule detection, but similar considerations also hold for
nonfluorescent single-molecule detection methods. Fluores-
cent molecules are capable of generating a strong signal
because each fluorophore can emit up to a million photons
before it finally photobleaches. Fluorescence excitation,
however, also leads to an optical background signal due to
autofluorescence and light scattering.[25] In order to observe
a single fluorescent molecule, it is essential to reduce the
detection volume to a femtoliter (fL) volume—commonly by
using confocal microscopy, fluorescence correlation spectros-
copy (FCS), or total internal reflection microscopy (TIRF).
The requirement for a very small detection volume is
associated with two closely related problems that must be
addressed in order to achieve higher sensitivity with digital
assays. The first problem is analyte sampling. At very low
analyte concentrations, there are not enough molecules
present in an analyte sample to reach the detection volume
by diffusion on a reasonable timescale. For example, it was
estimated that it takes on average more than ten minutes for
a molecule present in a concentration of 1 fm to reach
a detection volume of 10 fL by diffusion.[26] Stochastic
fluctuations are the second problem.[27] At low analyte
concentrations, a small observation volume is randomly at
one time occupied by a single analyte molecule and, at
another time, empty. The so-called Poisson noise ((
p
n)/n)
depends on the number of counted events (n) and is negligible
in conventional analog assays where n is very large. For digital
assays, however, it presents a problem because a single
detection event of an analyte molecule does not contain
enough analytical information. Therefore, it is necessary to
make either many parallel measurements on a larger area or
many sequential measurements in the same detection volume.
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2. Enzyme Labels
ELISA has been successfully transformed into single-
molecule immunoassays. The generation of thousands of
fluorescent molecules per enzyme label molecule multiplied
by up to a million photons per fluorophore generates a very
strong signal that can be detected by simple wide-field
fluorescence microscopy. In particular, b-galactosidase from
Escherichia coli is an excellent enzyme label for single-
molecule applications because it is robust and can turn over
up to 1000 substrate molecules per second. Based on this
strategy, Rotman[28] reported the very first single-molecule
experiment already in 1961. The enzymatic substrate turn-
over, however, is a kinetic process and requires time, which
leads to product diffusion. Consequently, the signal is not
detectable at the same location as the analyte. There are two
options to spatially allocate the signal to the analyte.
2.1. Assays Based on Localized Product Deposition
In the easiest case, the enzymatic reaction generates
a product that precipitates around the analyte. The group of
Suzuki[29] designed a digital sandwich immunoassay on beads
by using a conjugate of detection antibody and horseradish
peroxidase. The enzyme label converted a fluorescence-
labeled tyramide substrate to a short-lived radical which
immediately coupled the fluorescent labels only to the
analyte-bearing beads. This led to a high local fluorescence
signal at the site of analyte binding. It was noted, however,
that the detection of the tyramide signal on the beads by flow
cytometry was less efficient than that of digital ELISAs in
confined environments.
2.2. Assays in Confined Environments
Alternatively, the enzyme label converts a substrate to
a soluble fluorescent product. In this case, the reaction must
be confined in a very small compartment in order to prevent
product diffusion.[30] The concentration of the reaction
product exceeds the detection threshold in small confined
volumes. For example, a single molecule of b-galactosidase
enclosed in a volume of 50 fL (50 mm3) can produce a fluo-
rophore concentration of 2 mm in 1 min, which can be easily
detected via conventional epifluorescence microscopy.[31]
Enzymatic reactions were confined in water-in-oil emulsion[28]
or microfluidic droplets, fused silica capillaries,[32] virus
Figure 1. Progress in the development of immunoassays using optical detection schemes towards single-molecule detection. Radioisotopes were
replaced by labels based on enzymes, fluorescent molecules, and nanoparticles. Through the choice of an appropriate readout method, all these
labels can be exploited for measurement at the single-molecule level.
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capsids,[33] lipid vesicles,[34] or so-called femtoliter arrays. In
particular, femtoliter arrays and water-in-oil microfluidic
droplets have found analytical applications.
2.2.1. Femtoliter Arrays
Femtoliter arrays consist of a large number of homoge-
neous wells fabricated in the surface of optical fiber bun-
dles,[35] fused silica slides,[36] or polydimethylsiloxane
(PDMS).[37] The Walt group[38] pioneered single-molecule
immunoassays based on a fluorogenic enzymatic reaction in
femtoliter arrays, which was commercialized by Quanterix. In
the so-called Simoa platform (single-molecule arrays,
Figure 2), magnetic beads with a capture antibody were
dispersed in a sample. The bead concentration was typically
much higher than the analyte concentration. The beads were
magnetically separated and incubated with a biotinylated
antibody, followed by the addition of a streptavidin–b-
galactosidase conjugate. A high bead-to-analyte ratio resulted
in a small fraction of beads labeled with a single enzyme
molecule and a large excess of unlabeled beads. The beads
were loaded with a fluorogenic substrate onto a femtoliter
array and sealed with a gasket or oil film. A highly fluorescent
product accumulated only in wells that contained a bead with
a bound analyte molecule. The analyte concentration was
determined digitally by counting the number of fluorescent
wells. Prostate-specific antigen (PSA) and tumor necrosis
factor-a (TNF-a) were detected with a limit of detection
(LOD) of 1.5 fgmL@1 (& 50 am) and 2.5 fgmL@1 (& 150 am),
respectively. Other clinically relevant analytes included
cancer biomarkers,[39] urinary biomarkers,[40] p24 protein of
HIV,[41] and the neurofilament light chain protein (NFL),
a neuronal injury marker of various neurodegenerative
conditions and brain injuries. Traditionally, cerebrospinal
fluid must be obtained for analysis by lumbar puncture
because the concentration of NFL in the blood is too low for
a conventional ELISA. Shahim et al.[42] developed an ultra-
sensitive immunoassay with an LOD of 0.29 pgmL@1, which
enabled NFL measurements in the serum of healthy subjects.
Olivera et al.[43] determined tau protein in blood plasma
(LOD of 0.012 pg mL@1) to examine the relationship between
increased tau protein levels and chronical neurological and
psychological symptoms in military personnel after a trau-
matic brain injury. The ultrasensitive detection of biothreats
such as ricin has also been demonstrated.[44]
The Noji group[45] developed larger arrays of one million
femtoliter wells. Counting a very high number of individual
immunocomplexes in the arrays reduced the Poisson noise.
The assay was employed for the detection of PSA with an
LOD of 60 agmL@1 (& 2 am). The authors also showed that
the digital assay in femtoliter arrays is amenable to multi-
plexing by using two different enzyme/substrate labels.[46]
Recently, a competitive femtoliter array format was
demonstrated for the detection of small molecules such as
cortisol in saliva.[47] The assay achieved an IC50 down to
0.42 ng mL@1, which was 44 times lower than for a conven-
tional ELISA.
2.2.2. Microdroplets
Different methods for the generation of water-in-oil
microdroplets have been reviewed earlier.[30] Water-in-oil
droplets enclose the reactants and the product into pico- to
femtoliter volumes. While microdroplets generated by emul-
sification methods tend to be rather
heterogeneous, more homogeneous
microdroplets can be generated and
handled by microfluidic devices. Micro-
fluidic droplets separate the reactants
from the liquid substances, reduce the
assay volume, and enable rapid han-
dling, which increases the assay
throughput.[48] Microfluidic droplets
have also been used to study single
enzyme molecule reactions[49] and
single cells.[50]
Water-in-oil femtoliter droplets
generated by a microfluidic device
were used to establish a bead-based
ELISA (Figure 3).[51] A capture anti-
body on the surface of polystyrene
beads immobilized PSA. The presence
of PSA was then detected by a biotin-
ylated detection antibody and a strep-
tavidin–b-galactosidase conjugate
using fluorescein-di-b-d-galactopyra-
noside (FDG) as the substrate. The
enzyme product fluorescein was
recorded by fluorescence microscopy
while the beads were identified and
counted based on their red autofluor-
Figure 2. Single-molecule ELISA assay in femtoliter arrays. a) Many magnetic beads coated with
capture antibody are dispersed in the analyte sample. After an analyte molecule has been caught,
a biotinylated antibody forms the sandwich complex and serves as an anchor for a streptavidin-
modified b-galactosidase. b) The beads are loaded—together with a fluorogenic substrate—onto
a femtoliter array and sealed by a PDMS gasket. c) Scanning electron microscopy shows that only
one bead is loaded per femtoliter well. d) Fluorescence microscopy records the fluorescence
increase in wells that contain a bead with a captured analyte molecule. Reprinted with permission
from ref. [38]. Copyright 2010 Nature America.
Angewandte
ChemieReviews
10751Angew. Chem. Int. Ed. 2020, 59, 10746 – 10773 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.angewandte.org
escence. The microdroplet assay achieved an LOD of 46 fm
and a linear range of 0.046–4.62 pm.
Liu et al.[52] developed another type of enzyme-linked
immunoassay on magnetic beads for single-exosome counting
in microdroplets (droplet digital ExoELISA). Magnetic beads
were equipped with an anti-CD63 antibody to capture
exosomes. After sample incubation, a biotinylated detection
antibody and a streptavidin–b-galactosidase conjugate were
added to the beads. The beads were enclosed in 40 mm
droplets (& 33 fL) containing FDG. The fluorescence
increase of fluorescein was detected in each droplet contain-
ing a magnetic bead with captured exosome. A bead-to-
droplet ratio of 0.3 was employed to ensure that only one
magnetic bead was enclosed in a given droplet. The assay
achieved an LOD down to 10 enzyme-labeled exosome
complexes per microliter (& 10 am).
An competitive bead-based immunoassay utilizing micro-
droplets was reported for the detection of a-fetal protein
(AFP).[53] AFP was captured by antibody-coated magnetic
beads followed by the addition of a biotinylated detection
antibody and a streptavidin–b-galactosidase conjugate. After
magnetic separation, the unbound streptavidin–b-galactosi-
dase was injected into a microfluidic chip to generate
microdroplets with FDG. The microdroplets were collected
into a microtiter plate and fluorescent droplets containing
free streptavidin–b-galactosidase were counted under a fluo-
rescence microscope. This indirect digital concentration
readout reached an LOD in the fm concentration range.
The Di Carlo group[54] developed
a microfluidic digital homogeneous
entropy-driven biomolecular assay
(dHEBA) for the detection of influenza
A. Upon nucleoprotein binding, nucleic
acid labeled antibodies formed a catalyti-
cally active complex that drove a hybrid-
ization/displacement reaction on a multi-
component nucleic acid substrate and gen-
erated many fluorescence-labeled oligonu-
cleotides. The dHEBA format enabled the
detection of influenza A nucleoprotein in
a concentration of 4 am in approximately
10 min without the need for a purification
step.
3. DNA Labels for PCR Amplification
The polymerase chain reaction (PCR)
amplifies DNA—in principle starting from
a single template strand—exponentially to
very high copy numbers of DNA.[55] Drop-
let microfluidics on a microchip enables the
rapid isolation of single DNA strands and
subsequent PCR amplification in pico- or
femtoliter reaction containers.[56] For exam-
ple, a digital PCR was performed in rota-
tional chips to detect viral RNA isolated
from single HIV viruses.[57] Wells of differ-
ent volumes were employed in the chip to
enable quantification over a wider dynamic range. The assay
achieved an LOD of 40 RNA molecules per mL.
Similar to the digital readout of single enzyme molecule
labels, a digital immuno-PCR can be implemented if the PCR
reaction is enclosed in microdroplets. The droplet-based
digital immuno-PCR (ddIPCR) used magnetic beads as
a solid support, DNA as a marker and PCR for signal
amplification, for example, for the detection of PSA.[58] The
ddIPCR was performed in three steps as shown in Figure 4.
First, the PCR reaction mixture was emulsified to generate
tens of thousands of water-in-oil droplets per microchip.
Subsequently, the samples underwent thermal amplification
cycles and the number of positive droplets was determined by
end-point fluorescence detection. In the last step, the number
of DNA copies was calculated based on the Poisson distribu-
tion. The ddIPCR can usually improve the LOD by 100- to
10000-fold compared to a standard ELISA. It was noted,
however, that the washing steps and the microfluidic droplet
system cannot be easily combined. The LOD for PSA was
0.48 ng mL@1 with a linear range of 0.5–30 ngmL@1. The
concentration analysis of human serum samples correlated
well with a commercial reference immunoassay.
The digital PCR was combined with a proximity ligation
assay (PLA) to improve the precision of the assay.[59] Target
proteins such as the cytokine IL-6 were immobilized on
magnetic beads and detected by two types of DNA-modified
antibodies that are capable of forming a pair of PLA probes.
If both antibodies bound to the protein, the PLA probes were
Figure 3. Scheme of single-molecule immunoassay in femtoliter-sized droplets. a) Antibody–
antigen complex formation on beads. b) Beads with or without immunocomplex are
encapsulated in droplets with the substrate and incubated on chip in traps to collect the
fluorescent products of single-enzyme labels. c) Three droplet populations can be distin-
guished: i) droplets without a bead, ii) those containing a bead without immunocomplex,
and iii) those containing both a bead and immunocomplex, which exhibit a positive
fluorescence signal due to the enzymatic activity of a single b-galactosidase label. Reprinted
with permission from ref. [51]. Copyright 2013 American Chemical Society.
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joined by DNA ligation. The ligated DNA reporter strand was
then amplified by rolling circle amplification, and the
amplified DNA was detected via fluorescent DNA probes.
Because standard rolling circle amplification is not quantita-
tive, the ligated DNA strands were compartmentalized
individually by using a microfluidic device, and the protein
concentration was determined digitally by counting fluores-
cent microdroplets.
4. Fluorescent Molecular Labels
The detection of molecular labels at the single-molecule
level relies on fluorescence spectroscopy and microscopy.
Confocal microscopy and total internal reflection microscopy
(TIRF) efficiently reduce the detection volume and the
concomitant background signal, which enables the detection
of single fluorescent label molecules. When crossing a focused
laser beam in a confocal microscope set-up, individual
fluorophores emit bursts of photons that are detected.[60]
The residence time depends on the diffusion of the fluoro-
phore through the beam path (with a typical active volume of
a few femtoliters) and on photobleaching. Cyanine dyes were
proposed for such applications as the excitation within 650–
700 nm is well compatible with the spectral window of low
light scattering and autofluorescence of biological substances
including blood. Even epifluorescence has more recently
been reported to enable single-fluorophore detection. How-
ever, the type of microscopy is not relevant for the assay
design as long as it allows for the detection of a single
fluorescent molecule. Thus, we have organized this section
according to different assay formats. Fluorescence counting of
single protein analyte molecules immobilized on a surface by
capture antibodies seems in gen-
eral to be more sensitive than
correlation techniques in solu-
tion.
4.1. Detection of Surface-Bound
Analytes
Lçscher et al.[61] developed
a sandwich assay for the detec-
tion of single cardiac actin mol-
ecules. The scanning system
employed a single-photon-count-
ing avalanche photodiode
together with a CCD camera
for imaging under 635-nm laser
excitation. A glass surface was
coated with a cellulose layer to
reduce nonspecific binding. Con-
focal microscopy reduced the
optical background by minimiz-
ing the detection volume, which
enabled the evaluation of photon
bursts originating from individ-
ual molecules.
A particular kind of bioaffinity assay, the so-called pull-
down assay, has been used for the identification of protein–
protein interactions. The Ha group[62] developed a single-
molecule pull-down assay (Figure 5). A capture antibody was
immobilized in a flow chamber coated with polyethylene
glycol (PEG) and biotin. Streptavidin was added to the flow
chamber, followed by the addition of a biotinylated anti-His
antibody, which captured overexpressed His6-tagged yellow
fluorescent protein (YFP) from cell extracts. Individual YFP
molecules were detected by TIRF microscopy. A stepwise
decrease of the fluorescence intensity during single-molecule
bleaching experiments enabled the identification of dimeric
and trimeric YFP molecules. Individual protein kinase A
(PKA) complexes were detected by a two-color single-
molecule pull-down assay. In its inactive form, PKA is present
as a tetramer that consists of two catalytic and two regulatory
subunits. Cyclic adenosine monophosphate (cAMP) activates
the enzyme and leads to tetramer dissociation. The inves-
tigation of the stoichiometry of individual PKA complexes is
essentially not possible using conventional analog detection.
Burgin et al.[64] developed a single-molecule assay for the
detection of enhanced green fluorescent protein (EGFP) and
tumor suppressor protein p53. A microfluidic chip was
mounted onto a TIRF microscope under 473-nm laser
excitation. Two methods for absolute protein quantification
were used for the digital readout. In the accumulation method
(Figure 6a), the analyte was observed over a defined time
period, during which the number of fluorescent spots
increased until individual EGFP molecules were no longer
distinguishable as diffraction-limited spots. In the detect and
bleach method (Figure 6b), fluorescent spots were counted,
bleached, and after a fixed time interval counted again. Both
images were subtracted to identify newly arrived and
Figure 4. Scheme of ddIPCR. a) Antibody-coated magnetic beads capture the antigen (1). A biotinylated
antibody (2), streptavidin (3), and biotinylated DNA sequence from Aspergillus fumigatus (4) are
sequentially added. b) The magnetic beads are resuspended in a reaction mixture and emulsified. After
ddIPCR, the numbers of negative and positive droplets are counted. Reprinted with permission from
ref. [58]. Copyright 2018 Royal Society of Chemistry.
Angewandte
ChemieReviews
10753Angew. Chem. Int. Ed. 2020, 59, 10746 – 10773 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.angewandte.org
bleached molecules. Protein p53 was detected in the accumu-
lation method by using a labeled detection antibody.
Zhang et al.[65] developed a digital ATP assay using split
aptamers. A coverslip was bound to a glass slide with a 5-mm
hole in the center, followed by surface activation with plasma.
A mixture of poly(l-lysine)-poly(ethylene glycol)-biotin
(PLL-PEG-biotin) and PLL-PEG was added to the activated
coverslip. Next, streptavidin was added, and a biotinylated
Cy3-3’-labeled split aptamer was bound to streptavidin. The
analyte ATP was added together with the other Cy5-3’-
labeled aptamer. The coverslip was placed on an epifluor-
escence microscope, and the emission of the two dyes was
collected simultaneously on the same EM-CCD camera.
Diffraction-limited spots of a mixed color indicated specific
binding, whereas spots with only one color indicated non-
specific binding. The assay achieved an LOD of 100 fm and
a working range of 1 pm to 5 nm.
Weng et al.[66] developed an aptasensor for the detection
of small molecules. The hairpin-shaped aptamer immobilized
on a glass slide changes its conformation to an open state
upon analyte binding (Figure 7). Fluorescently labeled short
ssDNA probes bound preferably (but not exclusively) to the
open conformation and the fluorescence trajectories of
individual aptamers were monitored by TIRF microscopy.
As the binding of the fluorescent probe followed different
kinetic patterns depending on the conformation of the
aptamer, the kinetic fingerprints were used to distinguish
between nonspecific binding and analyte binding. Only spots
that showed the signature of specific binding were counted to
determine the analyte concentration. The assay achieved
Figure 5. Scheme of single-molecule pull-down assay. A cell lysate is
applied directly onto a coverslip for single-molecule TIRF microscopy.
Specific antibodies on the coverslip capture protein complexes. Prey
proteins associated with the bait protein are detected via a fluorescent
dye fused to the prey. Reprinted with permission from ref. [63].
Copyright 2011 Macmillan Publishers Limited. Figure 6. Different approaches for digital protein quantification. a) For
low analyte concentrations, the accumulation method counts the
increasing number of fluorescent spots. If the distance between two
fluorescent molecules is below the diffraction limit, they appear as one
spot and cannot be distinguished anymore. b) In the detect and
bleach method, fluorescent molecules are counted after a certain time
interval and subsequently bleached. The bleaching step keeps the
average number of fluorophores bound to the surface at a constant
level such that higher concentrations can be determined. Reprinted
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LODs of 0.3 pm for adenosine, 0.35 pm for acetamiprid, and
0.72 pm for PCB-77 in spiked chicken meat extract.
4.2. Laser-Induced Fluorescence Detection inside a Capillary
The Yeung group pioneered the use of capillary electro-
phoresis for single-molecule detection.[36] In capillary electro-
phoresis, an electric field drives the sample through the
illumination volume, which is small enough to allow for the
detection of individual fluorescent molecules. Based on the
electrophoretic mobility of individual fluorescently labeled
antibodies, fluorescent immunoassays were established.[67]
Antibodies bound to an analyte molecule have lower electro-
phoretic mobility and can thus be distinguished from free
antibodies using cross-correlation. Individual fluorescence-
labeled antibodies were recorded in the capillary by wide-
field microscopy using a 20 X objective (numerical aperture
(NA) 0.75) and an intensified CCD camera.
Stimulated by the need for reliable and sensitive assays for
cardiac troponin, a diagnostic marker of acute myocardial
infarction, the Erenna platform was developed.[68] First,
a sandwich immunoassay was performed in a microtiter
plate, and the bound labels were then released and inserted
into a capillary electrophoresis device. As only a single
fluorescent molecule passed through the detection volume
during the observation interval, individual analyte molecules
were counted, and an LOD of 1.7 pg mL@1 was achieved. In
combination with magnetic beads, it was possible to detect
troponin I levels of 0.2 pg mL@1, which are typically found in
healthy individuals (0.3 to 9 pgmL@1).[69] Esparza et al.[70] used
the Erenna assay to study amyloid-beta (Ab) aggregation and
deposition in AlzheimerQs disease. Concentrations as low as
1.56 pg mL@1 (0.18 pm) of soluble Ab oligomers were detect-
able above background, and the limit of quantification (LOQ)
was 6.25 pg mL@1 (0.72 pm). The method was applied to
measure the Ab oligomers in human cortical tissue homoge-
nate. Wild et al.[71] detected mutant huntingtin protein
(mHTT) in cerebrospinal fluid. The mHTT is a promising
biomarker for monitoring Huntington disease progression,
but due to its predominantly intracellular localization, the
concentration in the cerebrospinal fluid is very low (below pm
even in patients in an advanced state of the disease) and
conventional methods are not sensitive enough to detect it.
The Erenna assay provided an LOD of 40 fm and the authors
found a significant difference in levels of mHTT in carriers of
the genetic mutation in the premanifest stage and in different
later stages of the disease.
For the detection of the fertility-related human gonado-
tropin follicle-stimulating hormone (FSH), the laser beam
was shaped into stripes, and 10 “superpixel” zones were
evaluated using a CCD camera.[72] Magnetic beads served as
a solid support for the immunoassay. The LOD for FSH was
34 fm for a few hundreds of fluorescent events counted above
the background in 12 s corresponding to a few zeptomoles of
labeled antibodies.
The combination of several excitation lasers (blue
488 nm; green 543 nm; red 635 nm; infrared 730 nm) and
four single-photon-counting modules allowed for the imple-
mentation of multiplexed assays.[73] Confocal microsecond-
scale alternating-laser excitation (ALEX) single-molecule
fluorescence spectroscopy was used to probe the fluorescent
acceptor (A) without energy transfer (FRET) and provided
donor (D) excitation-based data for each single molecule.
Distinct emission signatures were recovered for interacting
species through determination of the FRET efficiency E,
which relates to the D–A distance, and distance-independent
stoichiometry-based ratio S. The combination of E and S on
two-dimensional histograms allowed for a virtual sorting of
single molecules. This technique was evaluated by determin-
ing 25 DNA sequences, 6 tumor markers, 8 bacterial gene
markers, and 3 drug-resistance determinants.
Figure 7. A) Scheme of a hairpin-shaped aptasensor immobilized on a slide surface. Analyte binding results in a conformational change and
binding of a complementary fluorescent ssDNA probe. Single-molecule trajectories B) without and C) with 50 pm adenosine are distinguishable.
Reprinted with permission from ref. [66]. Copyright 2019 American Chemical Society.
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troscopy (FCS) records diffusion at
the single-molecule level. Equilib-
rium concentration fluctuations
due to Brownian motion are mea-
sured as spikes of fluorescence
intensity within a small sampling
volume. A concentration in the
nanomolar range should be
attained for sub-femtoliter detec-
tion volumes to allow for following
individual fluorescence-labeled
molecules. Such a small detection
volume can be obtained using con-
focal microscopy or multiphoton
microscopy. The sensitivity of FCS
depends mainly on the brightness
of the fluorescent probe and on the
detection volume.[74] Evaluating
fluorescence intensity fluctuations
over time by an autocorrelation
function yields information on the
diffusion rates and the concentra-
tion of the fluorescent molecule.[75] The diffusion time
depends on the size and shape of the target molecule, on
the viscosity of the solution, and on the size of the focused
laser beam. FCS can be exploited to follow molecular
interactions with other molecules because the diffusion time
decreases each time when another molecule has bound.[76]
FCS has found applications in in vitro and in vivo studies of
protein–protein interactions, nucleic acid interactions, enzy-
matic activities, and membrane diffusion.[77]
The detection of fluorescence-labeled molecules at the
single-molecule level by FCS is applicable for the implemen-
tation of homogeneous immunoassays that avoid washing and
separation steps as well as nonspecific binding to surfaces,
which becomes increasingly important at low analyte con-
centrations.[75] On the other hand, FCS is prone to background
interferences caused by autofluorescence, light scattering,
quenching, and potential aggregation of the assay compo-
nents. The simplest scheme of an FCS immunoassay is based
on following the changes in the diffusion rate after the
formation of the immunocomplex (Figure 8). Chatterjee
et al.[76] employed a sandwich assay for the detection of the
neuronal cell adhesion molecule contactin-2 in cerebrospinal
fluid. The assay was based on two different anti-contactin
antibodies. One antibody was labeled with Alexa Fluor 488
and the other one was unlabeled. The formation of the
sandwich immunocomplex of both antibodies with the analyte
increased the diffusion time, which was evaluated from the
autocorrelation curve. The authors reached a limit of
quantification of 0.2 ngmL@1.
Changes in the diffusion rates were also recorded by FCS
to implement a competitive assay for the detection of the
mycotoxin fumonisin B1 (FB1).
[78] The analyte FB1 competed
with a tracer consisting of FB1 and Alexa Fluor 488 for the
free binding site of the antibody. The assay provided an LOD
of 1 ng mL@1.
The sensitivity towards the formation of immunocom-
plexes closer in size can be enhanced by using fluorescence
cross-correlation spectroscopy (FCCS). FCCS uses two spec-
trally different fluorescent probes, which can be simultane-
ously excited using two separate excitation wavelengths and
detected in two different channels. The amplitudes of the
cross-correlation curves are calculated to measure the inter-
actions of the fluorescent probes with the analyte. Compared
to conventional FCS, the use of two labels increases the
sensitivity and especially the selectivity of FCCS in the
quantitative measurement of biomolecules.
The Klenerman group[79] developed a sandwich assay
based on the counting of coincidence spikes of two labeled
antibodies. Compared to conventional FCCS, the data
evaluation was simplified because only the number of spikes
was counted, which corresponds to both labels being present
in the confocal volume at the same time. Protein G and herpes
simplex virus were detected with an LOD of 50 fm.
Miller et al.[80] demonstrated a sandwich FCCS-based
assay for the detection of human chorionic gonadotropin
and the prion protein (Figure 9). Two lasers were alternated,
and the emissions of different fluorescent labels were
measured using separate detectors to eliminate spectral
cross-talk and reduce the probability of false positive cross-
correlation.[81] The fluorophores were chosen in such a way
that their emission is separated, reducing the overlap of the
emission and the possible energy transfer. To eliminate
aggregation effects on the cross-correlation curves, cross-
correlations on short time sections were calculated and those
displaying the highest level of fluorescence (top 1% of the
intensity distribution) were discarded. The method provided
Figure 8. a) FCS setup. A laser is focused to excite fluorescent molecules in a confocal volume.
Fluorescence intensity fluctuations due to Brownian motion are measured in solution by a photodiode
connected to an optical fiber. b) The emitted photons are collected and plotted as time-dependent
intensity changes. c) The autocorrelation curves show an increase in the diffusion time after
formation of the immunocomplex (g) compared to the antibody alone (c). Reprinted with
permission from ref. [76]. Copyright 2017 Elsevier.
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LODs of 100 pm (human chorionic gonadotropin) and 2 nm
(prion protein) with an analysis time of 40 min.
5. Nanoparticle Labels
In recent years, various kinds of nanomaterials have been
introduced as labels for immunoassays in order to enhance
the assay performance.[20a] In particular, NPs with luminescent
or plasmonic properties, which allow for a convenient optical
readout, are suitable for single-molecule analysis.[82] Com-
pared to molecular labels, NPs display generally higher
signals, which allows for an easier readout. On the other
hand, their larger size can be a drawback in terms of steric
hindrance of the immunocomplex formation as well as
a potentially higher degree of nonspecific binding.
5.1. Semiconductor Nanoparticles
Quantum dots (QDs) are fluorescent semiconductor
nanocrystals with dimensions typically between 1 and
10 nm. The photoluminescence properties of QDs can be
tuned by changing the nanocrystal size, making it possible to
adjust emission wavelengths in the range of 380 to 2000 nm.[83]
Compared to conventional fluorophores, QDs provide higher
emission intensities, better photostability, wider excitation
spectra, and narrower emission bandwidths.[84] This allows for
an easier detection of individual QDs compared to conven-
tional fluorophores.
5.1.1. Detection of Surface-Bound Analytes
Liu et al.[85] developed a sandwich immunoassay based on
QD labels. Capture antibody-coated QDs and detection
antibody-coated QDs were mixed with the sample, and then
immobilized onto a positively charged coverslip. Mixed color
spots (yellow) were counted under a fluorescence microscope.
Carcinoembryonic antigen (CEA) was detected with an LOD
of 6.1 pm. The same group[86] implemented a homogeneous
sandwich immunoassay that employed only one type of label.
Capture and detection antibodies were conjugated separately
to 655QD. After formation of a sandwich immunocomplex
with the analyte, the QD emission was monitored through
a diffraction grating placed in front of a CMOS camera of the
microscope. The grating divided the emission into a zeroth-
order spot and a first-order streak. Because of the diffraction
limit, it was not possible to distinguish between unbound QDs
and the immunocomplexes. The QDs were oxidized during
excitation, and the first order streak shifted to shorter
wavelengths. The oxidation of the QDs started at different
times and proceeded at different rates, which split the first
order streak into two smaller streaks. The number of split
streaks was proportional to the number of analyte molecules.
The LODs for CEA and AFP were 6.7 fm and 3.4 fm,
respectively.
5.1.2. Detection in Microchannels
The Nie group[87] implemented a sandwich immunoassay
for virus detection based on the parallel detection of red and
green fluorescent NPs in a microfluidic channel under 488-nm
laser excitation. The immunocomplex was detected by
monitoring the coincidence of photon bursts in the red and
green detection channels. In this way, wild-type and mutated
respiratory syncytial viruses were quantified in parallel with
an LOD of 4 X 106 plaque-forming units (PFU).
Zhang et al.[88] developed an aptamer-based single-QD
FRET assay for the detection of cocaine. They first designed
a signal-off assay by assembling a sandwich of a 3’-biotiny-
lated oligonucleotide, a cocaine aptamer and a 3’-Cy5-labeled
oligonucleotide. The sensitivity of the system was investigated
by plotting the Cy5 burst counts against the ratio of Cy5 to
605QD from 0 to 24. It was possible to distinguish between
single Cy5 labels. The sandwich complex was dispersed in
a diluted cocaine sample to capture the analyte, and then
a commercial streptavidin-functionalized 605QD (605 nm
emission) was added to capture the aptamer complex. In
the presence of a high amount of cocaine, no FRET signal was
observed due to the release of the Cy5-oligonucleotide after
analyte binding. The signal-off assay achieved an LOD of
0.5 mm for cocaine, which is comparable to other electro-
chemical and enzyme-based assays. The generally low sensi-
tivity was explained by the poor affinity of the aptamer
towards cocaine. Additionally, a signal-on assay was designed
by forming a sandwich of a 3’-biotinylated oligonucleotide
and 5’-Cy5-oligonucleotide, the cocaine aptamer, and a 3’-
Iowa-black-oligonucleotide, which quenched the emission of
the 605QD/Cy5 FRET. In the presence of cocaine, the
quencher containing the oligonucleotide was released, and
Figure 9. In FCCS, two fluorescence-labeled antibodies bind to the
analyte. Black line: cross-correlation of labeled antibodies without
analyte (antigen); red line: cross-correlation of labeled antibodies in
the presence of the analyte. Reprinted with permission from ref. [80].
Copyright 2009 American Chemical Society.
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the FRET emission between the 605QD and Cy5 was
detected. A 488-nm argon laser was focused on the capillary
(50 mm inner diameter), and photon bursts of 605QD and Cy5
were detected simultaneously by two avalanche photodiodes
(APD).
A high-throughput assay was developed in a very narrow
channel (1–2 mm width and height) integrated in a chip system
(Figure 10).[89] Semiconducting polymer dots (Pdots) were
modified with streptavidin and the binding of biotin-Alexa647
was investigated. Au NPs were added to the solution as an
internal standard to compensate for instrumental fluctuations.
The platform combined confocal fluorescence detection with
narrow channels, which made it possible to count photon
bursts corresponding to individual NP-labeled molecules.
Additionally, the dual laser excitation scheme enabled the
quantification of the number of fluorophores per NP. This is
a very promising technique for the characterization of
different nanoconjugates.
5.1.3. Fluorescence Correlation Spectroscopy
To distinguish two components by FCS, at least a twofold
difference in their diffusion coefficients is required, which
corresponds to approximately an eightfold mass difference (in
the case of an idealized compact hydrodynamic sphere).[90]
This can be a limiting factor for the analysis of associations of
particles with similar mass. If small fluorescent label mole-
cules are replaced by larger NPs, however, the difference in
the diffusion times between the free immunoreagents and the
formed immunocomplex increases, and the sensitivity of FCS
is improved. For example, a sandwich aptamer-based FCS
assay utilizing QD-based probes was reported for the
detection of thrombin in serum with an LOD of 2.6 nm and
a working range of 5–500 nm.[91]
The general configuration of the FCCS requires the
alignment of the two lasers with different wavelengths to the
same focal spot, which makes the optical setup more
complicated than the conventional single-laser FCS. The
misalignment of the detection volumes can lead to a decrease
of apparent cross-correlation. The single-wavelength excita-
tion FCCS (SW-FCCS) developed by WohlandQs group[92]
overcame this limitation by the use of two probes, which
can be excited using the same wavelength, but their emission
is separated due to a large difference of the Stokes shifts. This
can be conveniently achieved by the use of QDs[93] or long
Stokes shift fluorescent proteins.[94] The group of Ren[95]
designed sandwich and competitive assays based on SW-
FCCS for the detection of alpha-fetoprotein (AFP). In both
approaches, 655QDs (655 nm emission) and Alexa Fluor 488
(520 nm emission) were chosen as the labels. The achieved
LODs were 20 pm (sandwich assay) and 180 pm (competitive
assay).
5.2. Photon-Upconversion Nanoparticles
The optical background of traditional fluorescence read-
out can be avoided by using photon-upconversion nano-
particles (UCNPs) that emit shorter-wavelength light under
near-infrared (NIR) excitation (anti-Stokes emission).[96]
UCNPs are lanthanide-doped nanocrystals and the most
efficient UCNPs consist of a hexagonal NaYF4 host crystal
doped with Yb3+ and Er3+ or Tm3+. The anti-Stokes emission
strongly reduces autofluorescence and light scattering. Fur-
Figure 10. A) Optical setup of the single-particle flow platform. Avalanche photodiodes APD1 and APD2 detect the fluorescence of Pdots and
Alexa647, respectively, while APD3 detects the backscattered light of Au NPs. B) Labeling and measurement procedure to quantify the number of
streptavidin molecules bound to the surface of Pdots. C) Fluorescence intensity traces of single-particle flow measurements of the Pdot-SA-biotin-
Alexa647 complex. Blue (top) and red (bottom) traces are from Pdots and biotin-Alexa647, respectively. The dotted red line indicates the time at
which the 633 nm laser was turned off. The five labeled peaks indicate the Pdot-SA-biotin-Alexa647 complex since both blue (Pdot) and red
(biotin) fluorescence were detected simultaneously. Reprinted with permission from ref. [89]. Copyright 2018 American Chemical Society.
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ther advantages of UCNPs include a high photostability and
multiple and narrow emission bands that can be tuned
individually for the multiplexed detection of several analytes
in parallel.[97] For example, the group of Soukka[98] developed
a multiplexed array-in-well assay to determine the immune
status against virus infections in human serum samples by the
spatial arrangement of several virus antigens on a microtiter
plate. Additionally, two types of UCNP labels with different
emission colors (Er-doped: green; Tm-doped: blue) were
used to distinguish between IgG and IgM antibody classes.
The groups of Fan[99] and Jin[100] further enhanced the
multiplexing capabilities of UCNPs by combining wave-
length- and lifetime-based encoding. The combination of
several lifetime populations and emission bands laid the
foundation for a very high encoding capacity. This approach
was used for the detection and differentiation between the
DNA of nine subtypes of human papillomavirus,[99] but can
also be readily adapted for multiplexed antibody-based
assays.
5.2.1. Detection of Surface-Immobilized Analytes
We have developed a method for visualizing individual
UCNPs (NaYF4 :Yb
3+,Er3+) by conventional epiluminescence
microscopy and applied it for the sensitive detection of the
cancer marker PSA.[22a] Individual sandwich immunocom-
plexes consisting of 1) an anti-PSA antibody immobilized on
the surface of a microtiter well, 2) PSA, and 3) an anti-PSA
antibody–UCNP conjugate were counted under an upcon-
version wide-field microscope equipped with a 980-nm laser
excitation source (Figure 11). The single-molecule (digital)
ULISA provided an LOD of 1.2 pgmL@1 (42 fm) PSA in 25%
blood serum and covered a dynamic range of three orders of
magnitude. The digital readout provided single-particle
resolution without instrumental background, which resulted
in ten times lower LOD compared to the classical (analog)
readout of luminescence intensity. An important advantage of
the digital readout is the resistance against NP aggregation. In
the analog mode, a large aggregate containing hundreds of
luminescent NPs can lead to a very high background signal.
By contrast, in the digital mode, each aggregate—regardless
of its size—only counts as a single binding event and has only
a marginal effect on the background signal. Recently, we have
prepared a detection label based on a conjugate of PEG-
coated UCNPs with streptavidin, which allowed to decrease
the label concentration and further improved the LOD by
a factor of 50 to & 20 fgmL@1.[22b]
Li et al.[101] designed a digital homogeneous sandwich
immunosorbent assay based on UCNPs (NaYF4 :Yb
3+,Er3+,
42 nm in diameter) for PSA. An antibody-coated UCNP,
PSA, and an antibody-coated Au NP formed an immuno-
complex. As the green upconversion luminescence over-
lapped strongly with the absorption spectrum of 50 nm Au
NPs, luminescence energy transfer (LRET) strongly
quenched the upconversion luminescence. Consequently,
the ratio of the visible particles in a flow cell and the
amount of UCNPs that was visible in the negative control
decreased. The assay achieved an LOD of 1.0 pm in buffer and
2.3 pm in serum.
5.2.2. Fluorescence Correlation Spectroscopy
If a sample such as blood or plasma is strongly autofluor-
escent, the FCS/FCCS signal of a label present in sub-
nanomolar concentrations is not detectable due to spectral
overlap. This effect can either be reduced by using brighter
labels or by measuring the cross-correlation of UCNP labels
to avoid optical background interference. Lahtinen et al.[102]
developed an assay based on upconversion cross-correlation
spectroscopy for the detection of thyroid-stimulating hor-
mone (TSH). Green (NaYF4 :Yb
3+,Er3+)- and blue (NaY-
F4 :Yb
3+,Tm3+)-emitting UCNPs were conjugated with anti-
TSH antibodies, and the cross-correlation was measured upon
binding of the analyte TSH. Compared to small organic
fluorophores, NP labels have a higher tendency to form
aggregates, bind non-specifically, and induce bridging of more
Figure 11. Single-molecule ULISA. A) Scheme of sandwich immunoassay; Ab = antibody. B) Wide-field upconversion microscope images of single
immunocomplexes carrying a UCNP label. C) Calibration curves of the digital (green) and analog ULISA (black). The number of UCNPs is given
by the diffraction-limited spots in (B) and the upconversion luminescence (UCL) is recorded by a microtiter plate reader.[22]
Angewandte
ChemieReviews
10759Angew. Chem. Int. Ed. 2020, 59, 10746 – 10773 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.angewandte.org
than two NPs. To suppress these effects, large intensity bursts
that were attributed to aggregates were removed before
calculating the auto- and cross-correlation functions.[103]
However, the smaller bursts were still causing strong varia-
tions of the amplitude, which affected the assay sensitivity.
The achieved LOD was 15 mIUL@1, which is above the range
of normal TSH concentrations in serum (0.3–5.0 mIU L@1).
5.3. Plasmonic Nanoparticles
Plasmonic NPs have been used in single-molecule immu-
noassays because they enable a highly sensitive readout based
on their light-scattering properties and spectral changes upon
analyte binding. The most common materials include gold
(Au NPs) and silver (Ag NPs). Au NPs are labels that are
most frequently used in immunoassays in general, finding
applications in lateral flow assays, electrochemistry, colori-
metric assays, and plasmonic sensing.[104] Ag NPs are less
stable because they are oxidized more easily, but they possess
higher extinction coefficients and stronger Raman and
fluorescence enhancement.[105] In both cases, the plasmonic
properties are strongly dependent on the shape and the size of
the NP.[106]
5.3.1. Dark-Field Microscopy
Dark-field microscopy is the most common method for
the detection of single plasmonic particles. In dark-field
microscopy, the illumination light is prevented from entering
the objective acceptance cone, whereas the light scattering
from immobilized NPs is collected by the objective lens.
Background scattering and reflection from interfaces can be
further reduced by optimizing the refractive indices.
Poon et al.[107] developed an antibody-based single-par-
ticle scattering intensity assay for the detection of various
clinical cancer markers such as AFP, CEA, and PSA. A gold
nanoprobe coated with a capture antibody was immobilized
in a flow cell on microscope coverslips. Then the analyte was
added, followed by a second Ag NP carrying the detection
antibody. Binding of Au and Ag NPs resulted in a threefold
increase of the scattering intensity and a spectral shift. The
LODs for all three analytes were in the range of 1 to 6 pm.
Wu et al.[108] developed a magnetic-bead-based sandwich
immunoassay for AFP, CEA, and PSA using Au NP detection.
First, a sandwich immunocomplex was formed by incubating
the sample with a biotinylated antibody and a second
unlabeled antibody (Figure 12). The immunocomplexes
were captured on streptavidin-coated magnetic beads. Au
NPs coated with a secondary antibody were added, and
unbound labels were removed by magnetic separation. After
washing, the Au NPs were released from the beads by
treatment with 8m urea. The free Au NPs were then
immobilized on a cationic coverslip and counted under
a dark-field microscope. Zhu et al.[109] developed a similar
sandwich immunoassay for PSA using a preconcentration step
on magnetic beads.
The Gooding group[110] showed the potential use of
commercial cameras as they appear in smartphones for the
high-throughput spectral readout of the localized surface
plasmon resonance (LSPR) spectra of up to 5000 individual
Au NPs (Figure 13). Anti-interleukin-6 (IL-6) antibodies
were conjugated to Au NPs and spin-coated on a glass slide.
A biotinylated anti-IL-6 antibody was attached to a 10-nm
streptavidin-modified satellite Au NP and then added to the
Au NPs immobilized on glass. The binding of the satellite Au
NP resulted in a redshift of the LSPR signal due to plasmon
coupling. The spectral shift of single Au NPs before and after
the addition of IL-6 was used to calculate the analyte
concentration. While the setup was not sensitive enough to
detect single binding events, single-molecule sensitivity may
be achieved by using bigger satellite particles (20–80 nm).
A method for extracting affinity constants based on
statistical fluctuations in equilibrium was proposed by Luth-
gens and Janshoff.[111] It is based on a single-molecule readout
of an array of isolated sensors, which can accommodate a high
amount of simultaneously bound analyte molecules. Aći-
mović et al.[112] employed this principle to follow antibody–
antigen binding kinetics on long timescales on the single-
molecule level. First, Au nanorods were modified with




10760 www.angewandte.org T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Angew. Chem. Int. Ed. 2020, 59, 10746 – 10773
thiolated PEG followed by binding of an anti-PEG antibody.
The signal fluctuations at equilibrium enabled the calculation
of kinetic parameters and analyte concentrations.
Yang et al.[113] developed a digital aptamer-based assay for
the detection of thrombin. A biotinylated anti-thrombin
aptamer was immobilized on streptavidin-coated magnetic
beads. Au NPs coated with a DNA sequence complementary
to the aptamer were introduced and bound to the aptamer. In
the presence of thrombin, the Au NPs were released, and the
beads were magnetically separated. The free Au NPs in the
supernatant were either counted individually under a dark-
field microscope by dispersing a drop on a coverslip (digital
detection) or—at high concentrations—by measuring the
absorption resulting from NP aggregation (analog detection).
Another aptamer-based thrombin assay was developed by Li
et al.[114] A glass slide was modified by Au NPs to bind
a thrombin-specific aptamer. Thrombin was specifically
captured, followed by another anti-thrombin aptamer to
form a sandwich complex. After the addition of Au NPs, NP
oligomers formed through Au–S binding, and the color
changed from green to yellow and red. Individual NPs were
detected under a dark-field microscope, and the thrombin
concentration was estimated from the intensity change of the
Au NPs. The assay detected thrombin with an LOD of 10 fm.
Chen et al.[115] increased the LSPR signal of individual Au
NPs by enzymatic amplification. When a single streptavidin
horseradish peroxidase conjugate bound to a biotinylated Au
NP, the resulting LSPR shift enabled the detection of single
molecules. The enzymatic precipitation of 3,3’-diaminobenzi-
dine further increased the colorimetric response by a factor of
50. This method can potentially be developed into a sandwich
immunoassay by coating the Au NPs with a capture antibody
and conjugating horseradish peroxidase with a detection
antibody.
5.3.2. Light Scattering Correlation Spectroscopy
Resonance light scattering correlation spectroscopy
(RLSCS) measures the fluctuations of resonance light
scattering in small volumes due to the Brownian motion of
single NPs. Noble metal NPs are excellent labels for RSLCS
because of their efficient resonance light scattering, which is
several orders of magnitude higher than scattering of small
organic molecules.[116] The RSLCS instrumentation is similar
to that of FCS, but no emission filter is needed. Like FCS, the
RLSCS immunoassays are based on the increase of the
characteristic diffusion time in the detection volume due to
the formation of an immunocomplex. RLSCS was used in
a sandwich immunoassay for AFP (LOD 1 pm)[117] and in
competitive assays for AFP (LOD 100 pm) and 17-b-estradiol
(LOD 10 pm).[118] Similar to FCS and FCCS, one of the major
limitations of RLSCS is the significant effect of NP label
aggregation. Although in both studies the particles were
coated by PEG to suppress the NP aggregation, in the
presence of a real sample matrix, the assay reproducibility in
serum was lower compared to the standard ELISA.
Fluorescence and scattering light cross-correlation spec-
troscopy (FSCCS) was used by Wang et al.[119] in a confocal
setup for measuring the scattering of labels based on Au NPs
and a fluorescent dye (Alexa Fluor 488) as a probe pair
(Figure 14). The advantage of FSCCS is the use of a single
488-nm laser as the excitation source for both the Au NP and
the fluorescent label. A sandwich immunoassay based on this
setup achieved an LOD of 3.1 pm AFP.
5.3.3. Surface Plasmon Microscopy
The adsorption of individual plasmonic NPs can be
followed in real time using surface plasmon microscopy.[120]
Changes in surface plasmon resonance (SPR) properties
Figure 13. Top: Color analysis using a commercial camera. The color of the Au NPs is transformed into a hue value that corresponds to a specific
wavelength and plotted in a histogram. Bottom: Color analyses using a spectrometer; each spot has to be processed individually. Reprinted with
permission from ref. [110]. Copyright 2018 Elsevier.
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affect the reflected light intensity, which is detected by an
image sensor.[121] The measurement can be based either on the
setup with a high-NA microscope objective[122] or on the
standard Kretschmann configuration.[123] While a high-NA
objective provides high resolution, the field of view is
typically limited to an area of 0.01 mm2. On the other hand,
the Kretschmann configuration provides a wider field of view
(over 1 mm2), but imperfections in the arrangement of object,
lens, and image planes degrade the performance and reso-
lution of the optical system. SPR imaging is typically used for
the characterization of homogenous films, where high reso-
lution is not necessary.[124]
The group of Mirsky developed a wide-field approach for
the detection and quantification of single NPs[121] and applied
it for the analysis of Au and Ag NPs in complex samples such
as wine, apple juice, and sunscreen (Figure 15).[125] The large
imaging area of the wide-field setup increased the probability
of detecting single NP adsorption events at low concentra-
tions. The signal strength was mainly determined by the size
and refractive index of the NPs, the distance from the
plasmonic substrate, and the performance of the optical
system. The adsorption of a single NP, however, only led to
a small signal change. To enhance the sensitivity, differential
images of local temporal and spatial intensity changes were
evaluated based on the changes between the two subse-
quently captured frames. The method provided an LOD of
106 NPs mL@1 (& 1.6 fm) and a working range of 106–
1010 NPs mL@1 with a measurement time of 1 min. The
sensitivity can be further improved by increasing the analysis
time or the sensing surface area.
Furthermore, the combination of surface plasmon mi-
croscopy with electrochemical analysis made it possible to
determine the composition of NPs.[126] This technique was
applied to the analysis of Ag and Cu NPs and achieved an
LOD of 104 NPsmL@1. Surface plasmon microscopy was also
employed for single-molecule detection of DNA hybridiza-
tion,[127] and the application to single-molecule immunoassays
would be straightforward.
5.3.4. Detection in Microarrays
Sevenler et al.[128] used Au nanorods as labels for the
detection of hepatitis B virus surface antigen (HBsAg) on
a protein microarray. An anti-HBsAg antibody was spotted
on an interferometric reflectance imaging sensing (IRIS)
substrate and incubated with the antigen, followed by the
addition of Au nanorods coated with another anti-HBsAg
antibody, and the particles were counted in an automated
imaging device under illumination by circularly polarized
light. Light reflected by the IRIS substrate was also polarized,
but the light scattered by Au nanorods was linearly polarized
along the longitudinal axis of the NPs and was separated
from the reflected light. The assay achieved an LOD of
3.2 pg mL@1.
Belushkin et al.[129] designed a sandwich immunoassay for
C-reactive protein (CRP). A gold nanohole array was coated
with an anti-CRP capture antibody. The array was immersed
in the analyte medium, washed, and immersed in a dispersion
of Au NPs that were coated with an anti-CRP antibody. Au
NPs in or close to the nanoholes could be detected because of
a decrease in the extraordinary optical transmission (EOT).
EOT is an SPR-based phenomenon that occurs when light
passes through a subwavelength-sized regularly shaped met-
allic film. Particles too far away from nanoholes were not
detected. Single Au NPs were counted under a microscope.
Figure 14. a) Setup for FSCCS. b) Spectral separation of excitation and emission wavelengths. c) Scattering and fluorescence signals and their
correlation curves for labeled species diffusing independently (left) or linked (right). ACF = autocorrelation curve, CCF =cross-correlation curve.
Reprinted with permission from ref. [119]. Copyright 2017 American Chemical Society.
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6. Bead Labels
6.1. Fluorescence Microscopy
While it is not possible to make a sharp separation
between NPs and beads, here we define beads as labels larger
than 100 nm in diameter. The larger size, on the one hand,
offers an easier way for detection but, on the other hand,
impedes the accessibility of the label to the analyte. The
Lçvgren group[130] was one of the first to employ a bead label
for the detection of single analyte molecules. Individual
europium-doped beads—with a diameter of 107 nm, very
close to NP size—were detected by time-resolved fluores-
cence (TRF). A microtiter plate was coated with a monoclonal
anti-PSA antibody and biotinylated PSA was added, followed
by the streptavidin-coated Eu beads. The analyte binding was
measured in the analog mode by time-resolved fluorometry
and in the digital mode by counting single bead labels under
a time-resolved microscope equipped with a 10 X objective
and a CCD camera. The assay achieved an LOD of
0.38 pg mL@1 of biotinylated PSA.
Wu et al.[131] used color-encoded magnetic beads to
simultaneously detect single virus particles of three different
types of avian influenza (Figure 16). Polystyrene beads were
coated first with g-Fe2O3, then with QDs displaying different
emission colors (green, yellow, red) and with antibodies
against avian influenza. The three bead types, each one
specific for a certain avian influenza type, were dispersed in
the sample and magnetically separated. The beads were then
loaded onto a PDMS microarray that was coated with
antibodies for the different virus types. After washing, only
beads that captured a virus particle remained in the array. The
assay resulted in an LOD of 0.02 pg mL@1.
Zhang et al.[132] embedded UCNPs of different colors and
in different ratios into polymer microbeads to generate codes
for the multiplexed detection of DNA. The combination of
n intensity levels with m colors resulted in (nm@1) unique
codes. The labels were detected at the single-bead level under
980-nm excitation by confocal microscopy. The DNA
sequence was identified based on the upconversion encoding
signal, while the presence and amount of the target sequence
was indicated by conventional fluorescent dyes.
Gite et al.[133] developed a sandwich assay consisting of
1) a magnetic particle, 2) an anti-Clostridium difficile capture
antibody, 3) C. difficile, 4) an anti-C. difficile detection anti-
body, and 5) a fluorescent microparticle. A mixture of
a visible-light-absorbing dye-cushion reagent and the density
agent iodixanol was dried on the bottom of each microwell
(Figure 17). The immunoreagents were added, and the
magnetic beads were pulled to the bottom of the microplate
with a magnet. The dye absorbed all visible light and stayed at
the bottom due to the density agent, resulting in a strong
reduction of the background fluorescence of unbound fluo-
rescent particles. Single fluorescent beads appeared as bright
pixels on a digital camera chip.
6.2. Bright-Field Microscopy
Tekin et al.[134] developed a microfluidic-based magnetic
bead counting assay for the detection of proteins in serum
(Figure 18). Magnetic beads (2.8 mm) were modified with
a capture antibody to preconcentrate a target protein from
fetal bovine serum. The beads were passed over over a glass
surface patterned with smaller antibody-modified magnetic
beads (1 mm). The larger beads were attracted to the surface
by a magnetic field, which allowed them to “roll” over
multiple smaller beads due to dipolar magnetic forces. An
immunocomplex formed when the antigen had a suitable
orientation on the bead. The drag force caused by the flow
had to be strong enough to release the particles when only
dipolar forces were present. The analyte concentration was
Figure 15. Surface plasmon microscopy for the detection of single NPs adsorbing to the sensor surface. Reprinted with permission from ref. [125].
Copyright 2016 American Chemical Society.
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determined by counting the bound large beads on a conven-
tional optical microscope. The combination of a magnetic
preconcentration step and digital counting of bound magnetic
beads in a microfluidic chip afforded an LOD of 60 am
(& 1 fgmL@1) TNF-a, equivalent to & 200
molecules in 5 mL of the sample.
6.3. Dark-Field Microscopy
Tethered particle monitoring is a bio-
physical technique used to characterize
changes in the length of a polymer tethered
to a particle on one end and a surface on
the other end. The Brownian motion of the
particle limited by the tether is usually
monitored optically. Schafer et al.[135] intro-
duced tethered particle monitoring in 1991
to follow the transcription of a DNA tem-
plate bound to an Au NP by RNA poly-
merase immobilized on a glass slide. Var-
ious modifications of the principle are
possible and can be used for monitoring
single-molecule binding
events in an immunoassay.
Visser et al.[136] utilized
the tethered particle moni-
toring in an aptamer-based
sandwich assay for throm-
bin. Magnetic beads were
modified with an anti-
thrombin capture aptamer
and the glass surface of
a flow chip was modified by
a detection aptamer. The
beads were tethered to the
glass surface by a 40-nm-
long dsDNA strand. When
the analyte was captured
between the aptamers, the
bead was anchored onto
the surface, and its mobility
was strongly reduced
(Figure 19), which was
monitored over time by
dark-field microscopy. The
binding and unbinding
events of hundreds of beads
were detected simultane-
ously. The rate of switching
between the two states, and
especially the lifetime of the
unbound state, was depen-
dent on the concentration of
thrombin in a range of 10–
300 nm. As the interaction
was reversible and all recog-
nition elements were bound
in the flow cell, the system is
amenable for continuous biomarker monitoring.
Silver et al.[137] developed a sandwich immunoassay for the
detection of PSA based on tethered particle monitoring.
Magnetic beads (2.8 mm) with immobilized antibody captured
Figure 16. Scheme of the multiplex assay for avian influenza viruses. Color-encoded
magnetic spheres—each coated with a specific anti-avian influenza virus antibody—are
dispersed in the virus sample. After magnetic purification, the particles are loaded onto
a PDMS array and digitally counted. Reprinted with permission from ref. [131]. Copyright
2019 American Chemical Society.
Figure 17. a) Detection of single fluorescent beads on one or a small group of pixels of a camera chip without
the need for microscope magnification. b) After immunocomplex formation, a magnet immobilizes the
magnetic beads at the bottom of a microwell. Only fluorescent beads near the surface are excited because
the dye absorbs the excitation light that penetrates deeper into the well. c) Fluorescent beads appear as
bright pixels on the digital camera. d) A comparison of a well with and without dye shows the efficiency of
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PSA from the sample matrix. After magnetic separation, the
beads were incubated with the biotinylated detection anti-
body and introduced into a flow cell. The beads carrying the
immunocomplex were captured by a streptavidin-terminated
DNA tether. This tether allowed the beads to move 12 mm
back and forth when the flow direction was changed by
manual syringe operation. Thus, specifically bound beads
were distinguished from nonspecifically bound beads and
counted using a low-magnification (10 X) dark-field micro-
scope. The assay achieved an LOD of 1 pm PSA.
Akama et al.[138] combined tethered particle monitoring
with an immunoassay in femtoliter arrays. In the “digital
homogeneous non-enzymatic immunosorbent assay”
(HoNon-ELISA), antibody-decorated magnetic particles
were used to separate the analyte from the sample matrix.
Then, they were magnetically pulled into the microreactors of
a femtoliter array chip for the confinement of the antibody–
antigen reaction. The antigen was recognized by another
antibody immobilized through a PEG linker to the well
surface. The sandwich complex tethered the particle to the
surface and limited its Brownian motion, which was moni-
tored for thousands of wells in parallel using bright-field or
dark-field microscopy and particle tracking analysis. Accord-
ing to the movement patterns, selectively captured particles
were discerned from nonspecifically bound ones, and indi-
vidual binding events were counted. The procedure did not
require any washing or signal amplification steps and reached
an LOD of 0.093 pg mL@1 PSA.
7. Label-Free Detection
Most label-free detection schemes are based on plasmonic
effects. While Section 5.3 describes the use of plasmonic NPs
as labels, here we focus on the arrangement of plasmonic
nanostructures to generate local hot spots, which are very
sensitive to analyte binding.[139] Localized surface plasmon
resonance (LSPR) has been used to follow the changes of
local refractive indices near plasmonic NPs. There are various
possibilities to link the refractive index changes to the
presence of the analyte, as demonstrated by numerous reports
of bulk LSPR-based immunoassays.[20a, 140] The high sensitivity
of LSPR can be exploited to characterize statistical distribu-
tions of molecular properties and to follow single-molecule
binding events.[141] Beuwer et al.[142] used correlated atomic
force microscopy (AFM) and optical microscopy to study how
the binding location affects the changes of LSPR signals. Au
NPs were used as a model analyte and bound to single-crystal
Au nanorods using cysteine–cysteine coupling.[143] In the
correlative approach, AFM was used to study the binding
locations, and the plasmon shifts were evaluated by single-
particle spectroscopy. A broad distribution of LSPR shifts was
Figure 18. Microfluidic-based magnetic counting assay. a) Scheme of a microfluidic chip. b) Large magnetic beads separate the target protein
from the matrix. c) The large beads roll over the patterned array of smaller beads that are magnetically attracted to the surface. d) A sandwich
immunocomplex is formed when the antigen and the large bead have a suitable orientation. e) Optical micrograph of the captured large beads on
the patterned array of small beads. A colored SEM photograph in the inset shows the large bead captured on the small beads. Reprinted with
permission from ref. [134]. Copyright 2013 Royal Society of Chemistry.
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observed for similar binding locations, which was attributed to
the size dispersion of the Au NPs. Binding of the Au NPs to
the tip of the rod led to stronger plasmon shifts than binding
to its sides. Since the probability of binding to various
locations of a nanorod differs,[144] the knowledge of the
binding location can help not only to determine the level of
sensor response but also to evaluate the binding constants.
Site-specific functionalization techniques can be used to
maximize the sensitivity and reduce the signal distribution.[145]
Lee et al.[146] designed plasmon rulers as sensors for the
detection of single molecules of matrix metalloproteinase
(MMP3). When two noble metal NPs exhibiting LSPR
approach each other, their individual surface plasmon reso-
nances couple, which generates a shift in the scattering
spectrum and can be detected by dark-field microscopy.
Beuwer et al.[147] used Au nanorods to detect the inter-
action of biotin and an anti-biotin antibody (Figure 20). They
functionalized the tips of Au nanorods with thiolated biotin
and detected the change in the scattering intensity of
individual nanorods. When the plas-
mon wavelength of a particle was
shorter than the 795-nm illumina-
tion light, the scattered signal
increased upon antibody binding.
The intensity change was stepwise
and irreversible due to the strong
biotin–antibody interaction. The
binding constants were calculated
from the mean waiting times and
followed a Poisson distribution. The
LOD was influenced by the number
of binding events in a certain time-
frame. As low analyte concentration
resulted in long waiting times, a high
number of particles had to be
observed, which was limited by the
field of view of the objective (ca.
50000 NPs). The high rate of bind-
ing events at high analyte concen-
trations required a fast camera
image acquisition. The shorter expo-
sure times were compensated by
a higher excitation power, which
was limited by photothermal heat-
ing of the particles.
Another emerging label-free
technique for the detection of
single molecules are whispering gal-
lery mode (WGM) microring reso-
nators, which trap light due to multi-
ple total internal reflections at
a curved boundary (Figure 21). An-
alyte binding to the optical ring
resonators results in a shift of the
resonance wavelength. Arrays of
microring resonators were used for
the multiplexed detection of five
protein biomarkers.[148] Single-mole-
cule sensitivity for protein or DNA
has been achieved. More recently, even single ions such as
Hg2+ and Zn2+ have been detected using a gold antenna
coupled to a WGM microresonator.[149]
Surface-enhanced (SERS) and tip-enhanced Raman
spectroscopy (TERS) also enable the label-free detection of
single protein molecules.[151] It is, however, difficult to employ
these techniques for measuring protein concentrations in
routine analytical applications.
8. Summary and Outlook
As new and low-abundance disease markers are inves-
tigated, there is a growing need for developing more sensitive
detection methods. Tables 1–3 summarize various assay types
for the digital readout of analytes that have been discussed in
the Review.
Single-molecule immunoassays have gained popularity in
clinical research and diagnostics and some platforms have
Figure 19. Tethered particle monitoring. a) Particles (orange) are modified by capture aptamers
(blue) and tethered to the substrate by a 40-nm dsDNA strand (black). The substrate is decorated
with detection aptamers (red). The image was recorded by dark-field microscopy (scale bar: 50 mm).
b) After thrombin (green) binding, the particle’s movement is restricted, which changes the motion
pattern. c) The particle mobility is continuously analyzed for hundreds of particles in parallel. The
mobility time traces of low and high analyte concentration reveal individual binding and unbinding
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been commercialized. Commercial single-molecule immuno-
assays offer complete solutions for the detection of a wide
range of biomarkers in clinical research, including cytokines,
hormones, and signaling proteins. As of September 2019,
Merck offered 49 ready-to-use immunoassay kits for the
Erenna system,[152] and Quanterix offered 130 kits for the
Simoa platform.[153] Furthermore, custom development serv-
ices and kits for in-house development of new assays by the
customer are available.
Although the detection of individual optical labels is
relatively easy using state-of-the-art detectors, it is still
a challenge to achieve the superior sensitivity of single-
molecule assays compared to that of analog assays. Recently,
the advantages of analog and digital detection modes have
been compared systematically using the same TIRF plat-
form.[154] Furthermore, the same analyte was used to evaluate
the performance of different assays.[155] Three immunoassay
platforms were assessed regarding their ability to detect sub-
picomolar concentrations of the protein biomarker
GAD65.[156]
Another important challenge is the simplicity and robust-
ness of the assay procedure. Even though single-molecule
assays can reach extremely high sensitivity, the need for
highly sophisticated instrumentation, well-trained personnel,
and long operation times can impede their commercialization.
Despite these challenges, single-molecule assays are finding
their way into real-world applications and can replace
conventional methods such as the ELISA or electrochemilu-
minescence assays. The possibility to detect only a few
biomarker molecules in a sample opens up many new
possibilities for enhanced diagnostics.
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Table 1: Digital assays for cancer biomarkers. The LODs were converted into molar concentrations wherever applicable.







FCCS with QDs AFP buffer 20 pm 20 pm–
5 nm
120 10 mL [95]
Resonance light scattering correlation spectrosco-
py
AFP buffer 1 pm 1 pm–1 nm 50 20 mL [117]
Fluorescence and scattering light cross-correlation
spectroscopy
AFP buffer 3.1 pm 5–580 pm 120 10 mL [119]
Light scattering correlation spectroscopy AFP buffer 100 pm 100 pm–
10 nm
120 20 mL [118]
Counting of spatially overlapping two-color QDs CEA plasma in buffer 6.1 pm 10.4–
666.7 pm
30 n/a [85]
Droplet microfluidics exosomes n/a 17 am 10 am–1 pm n/a n/a [52]
Simoa PSA 25% newborn calf
serum in buffer
98 fm 100 fm–
500 pm
n/a n/a [39]
Droplet array PSA buffer 2 am 1 am–
100 fm
120 n/a [45]
Femtoliter microfluidic droplets PSA buffer 46 fm 0.046–
4.62 pm
270 200 mL [51]
Droplet-based immunoPCR PSA buffer 17 pm 17 pm–
1 nm
120 30 mL [58]
Digital ULISA with UCNPs PSA 25% bovine serum
in buffer
42 fm 350 fm–
35 pm
150 100 mL [22a]
Digital ULISA with streptavidin-coated UCNPs PSA 25% bovine serum
in buffer
800 am 3.5 fm–
3.5 pm
210 100 mL [22b]
Single-UCNP enumeration PSA buffer 1 pm 0–500 pm 120 n/a [101]
Au NP enumeration with dark-field microscopy PSA buffer 35 pm 35–700 pm 170 95 mL [108]
Counting of gold nanorods by dark-field
microscopy
PSA buffer 280 am 350 am–
350 fm
195 100 mL [109]
Digital HoNon-ELISA PSA buffer 3.2 fm 3.2 fm–
3.2 pm
n/a n/a [138]
Tethered-bead immunoassay PSA buffer 1 pm 1–10 pm n/a 50 mL [137]
Simoa PSA,
TNF-a




360 100 mL [38]
Fluorescence-aided multiplexed molecule sorting CEA,
PSA,
AFP












Immunoassay based on spectral blueshifts of QDs CEA,
AFP










human serum 1.7 pm,
3.3 pm,
5.9 pm
0–300 pm n/a n/a [107]
n/a =not available; AFP=alpha-fetoprotein; CEA = carcinoembryonic antigen; PSA =prostate specific antigen; TNF-a= tumor necrosis factor alpha.
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Table 2: Summary of digital assays for other clinical biomarkers. The LODs were converted into molar concentrations wherever applicable.







Fluorescence colocalization ATP buffer 100 fm 1 pm–5 nm 45 25 mL [65]
FCS contactin-2 17 % CSF in buffer 1.5 pm n/a 60 10 mL [76]
Microarray-based plasmonic biosensor CRP buffer 225 fm n/a 120 100 mL [129]
Erenna cTnI 25 % human plasma
in buffer
74 fm n/a n/a 10 mL [68]
Bead-based Erenna cTnI 25 % human plasma
in buffer
8.7 fm 10 fm–
500 pm
180 100 mL [69]







120 20 mL [118]








Proximity ligation assay IL-6 n/a 5 fm 10 fm–1 nm n/a n/a [59]
Counting of Au NPs using dark-field micros-
copy with digital color analysis
IL-6 buffer 4.76 nm n/a n/a n/a [110]
Erenna mutant huntingtin 30 % cerebrospinal
fluid in buffer
40 fm 40 fm–1 nm n/a 45 mL [71]
Simoa NF-L 25 % human serum
in buffer
4.3 fm 4.2 fm–
26 pm
n/a 152 mL [42]











buffer 0.18 pm n/a overnight +
90 min
20 mL [70]
Aptamer-based assay using QDs thrombin buffer 2.6 nm 5–500 nm 60 10 mL [91]
Core–shell based aptasensor using
dark-field microscopy
thrombin buffer 2.54 fm 6–100 fm 30 n/a [113]
Aptamer sandwich sensor with Au Np
oligomers
thrombin buffer 10 fm 20 fm–20 nm n/a n/a [114]
Upconversion cross-correlation spectroscopy thyroid-stimulat-
ing hormone
buffer 15 mIUL@1 28.8–
2880 mIUL@1
30 30 mL [102]
Magnetic bead surface coverage assay TNF-a serum 60 am n/a 20 5 mL [134]
Single-molecule microarray tumor suppressor
protein p53
buffer 35 fm 100 fm–
100 pm
n/a 0.2 nL [64]
CRP =c-reactive protein; cTnI =cardiac troponin I; AFP= alpha-fetoprotein; FSH= follicle stimulating hormone; hCG =human chorionic
gonadotropin; NF-L = neurofilament light chain; TNF-a= tumor necrosis factor alpha.
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Gorris, Anal. Chem. 2017, 89, 11825 – 11830; b) M. J. Mickert,
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